News and Trends 16 Jan 2018 Two Proteins in the Brain Could Protect Against and Repair the Damage Caused by Parkinson’s …neurons of patients with Parkinson’s disease. VEGF and GDNF significantly reduced the loss of dopaminergic neurons and stimulated the production of new nerve cells. Current Parkinson’s therapies improve symptoms but… January 16, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 28 Nov 2017 New Gene Therapy for Parkinson’s will be Developed in the UK …developed by Synpromics in the development of a gene therapy for young-onset Parkinson’s disease (YOPD) in patients that start showing Parkinson’s symptoms before 50. Gene therapy for Parkinson’s is not… November 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jul 2017 Roche and Ireland’s Biggest Biopharma Take Their Parkinson’s Antibody to Phase II Prothena and Roche are advancing their Parkinson’s antibody to Phase II, triggering a new milestone payment from what is proving a lucrative deal for Prothena. Prothena, the largest biopharma in… July 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 29 Oct 2025 Parkinson’s disease: biotech’s pursuit for more therapies …the pathways, particularly the pathway involved in dopamine production, leading to Parkinson’s disease. New research related to Parkinson’s disease First-in-class Disease-modifying Therapy for Parkinson’s Disease – University of Colorado Boulder… October 29, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 7 Feb 2017 Swiss Parkinson’s Biotech raises Massive €29M in Series B from Top European VCs Top European VCs have invested €29M in Prexton Therapeutics to support two Phase II trials of its lead candidate foliglurax in Parkinson’s. An international team of top European biotech investors… February 7, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 16 Mar 2018 Lundbeck Signs Near €1Bn Acquisition of Swiss Parkinson’s Biotech Lundbeck is acquiring Prexton Therapeutics in a deal that could reach up to €905M if the Swiss company’s Parkinson’s treatment proves successful. Danish pharma Lundbeck has decided to boost its… March 16, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 28 Sep 2016 ITW: Prexton Therapeutics CEO explains Development of new Parkinson’s Drug For our first interview at the SACHS Conference in Basel yesterday, I met with François Conquet, founder and CEO of Prexton Therapeutics. His company’s treatment for Parkinson’s Disease just passed… September 28, 2016 - 1 minutemin - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 10 Jul 2017 Swiss Biotech Starts Phase II Trial to Treat Motor Symptoms of Parkinson’s …day when the medication wears off and symptoms get worse. Traditional approaches like the administration of levodopa target dopaminergic neurons, whose activity is affected by Parkinson’s. However, as the disease… July 10, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 20 Apr 2017 Newron’s Journey to Launch the First Parkinson’s Drug in 11 Years …than current medications to patients with Parkinson’s. Stefan discussed how failure can be an important part of success and what being European means in biotech. After struggling with the FDA… April 20, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 16 Nov 2017 German Diagnostics Firm Tackles Early Detection of Cancer, Alzheimer’s and Parkinson’s …(COPD), Alzheimer’s and Parkinson’s. Liquid biopsies, or diagnostic test based on blood samples, are a rapidly growing field. The technology has the potential to replace current diagnosis practices that are… November 16, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 12 Aug 2021 European Biotechs Fire up Deals to Develop Parkinson’s Treatments …following its seed investment from Parkinson’s UK. The field of Parkinson’s has been attracting deals throughout the year. Parkinson’s and epilepsy were the focus of Barcelona-based INBRAIN Neuroelectronics in March,… August 12, 2021 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
More News! 2 Mar 2023 Could new dementia treatment come from intestinal bacteria discovery? …regulation of movement and is deficient in Parkinson’s disease. Compared to Parkinson’s disease, the levels of these gut bacteria were higher in people with dementia with Lewi bodies. This may… March 2, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email